US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Biomarkers Market Research Reports & Industry Analysis

The high specificity required of biomarkers in research, drug development and clinical diagnostics creates significant diversity in the global biomarkers market. The greatest focus in biomarkers development is oncology with cancer biomarkers occupying the largest space at over 25% of the market. Biomarkers are parameters or analytes integral to or associated with a biochemical, anatomical, pathogenic, pharmacologic or molecular (genetic) process of clinical interest.

Biomarker discovery continues to power the development of in vitro diagnostic (IVD) tests used to diagnose disease and health conditions, predict patient response to therapy, and monitor therapeutic effects and patient health. Ideal biomarkers have excellent sensitivity and specificity in terms of identifying disease, determining disease state, or evaluating patient response to therapy. Biomarkers are generally proteins (products of gene expression) or nucleic acid sequences (either RNA or DNA); small molecules that are products of metabolism may also serve as biomarkers.

The proliferation of biomarkers is a result of greater clinical understanding of the interconnections between genetics, proteomics and gene expression, disease susceptibility, disease manifestation, and disease susceptibility to select therapies. Biomarkers can be classified as natural history markers (allow for the detection and isolation of a particular cell type), drug activity markers (indicate patient response to pharmological intervention), or surrogate markers (markers that can be used as an alternative to traditional endpoints such as morbidity and mortality to evaluate the effectiveness of a therapy in treating disease). Genomic research is expected to further expand the availability of biomarkers for various diseases and make significant contributions to personalized medicine.

In addition to cancer biomarkers, biomarkers are also available for cardiac function and episodes, other cardiovascular conditions, coagulation or hemostasis, endocrine function, blood sugar management, autoimmune disorders, inflammation, specific infectious diseases, sepsis, and neurological disorders. Over half of the biomarkers market exists in clinical applications, the rest in drug development, research and clinical trial applications. Biomarkers are broadly used for disease risk assessment, diagnosis, screening, treatment or therapy selection, and therapeutic monitoring.

RSS Feeds

Biomarkers Industry Research & Market Reports

< prev 1    3  4  5  6  
Conference Documentation: Advances in Cell Based Assays
11/11/2014 | published by: SMI Publishing, Ltd
... and strategies to accelerate go/no-go decision making in early and clinical development. Key academic, government and industry figures cover topics encompassing: Case studies in idiopathic pulmonary fibrosis (IPF) and molecular characterisation of solid tumors Interactive ...  |  read more...
USD 788.78
Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies)
9/4/2014 | published by: Kalorama Information
... proteins. This includes the study of which proteins are expressed, when and where they are expressed, structure of proteins, roles of proteins, and interactions of proteins. Proteomics is a large field that has focused on ...  |  read more...
USD 4,200
miRNA Research and Diagnostics Markets
9/4/2014 | published by: Kalorama Information
... the post-transcriptional level. These small bits of RNA, members of a class of non-translated molecules that do not produce protein, shut off gene transcription by base pairing with the target molecules.  They are now recognized as ...  |  read more...
USD 2,995
Biomarker Partnering Terms and Agreements
11/1/2014 | published by: Current Partnering
... partnering agreement structure Biomarker partnering contract documents Top biomarker deals by value Most active biomarker dealmakers The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and ...  |  read more...
USD 2,995
MicroRNAs in Cancer Drug Pipeline Update 2014
10/27/2014 | published by: BioSeeker Group AB
... with minimal toxicities either as a monotherapy or perhaps even more likely in a combinatorial drug setting. miRNA may also hold great potential as biomarkers, albeit a lot of work is a head of us ...  |  read more...
USD 6,746
Next Generation Sequencing (NGS) Global market - Forecast to 2020
11/6/2014 | published by: IQ4I Research and Consultancy
... introduction as Next generation Sequencing (NGS) has revolutionized the way the human genomes are being sequenced now a days. The time and cost to sequence has tremendously reduced since the first human genome was sequenced, ...  |  read more...
USD 4,500
Global Cardiac Biomarkers Market 2014-2018
11/5/2014 | published by: TechNavio - Infiniti Research Ltd.
... as acute coronary syndrome (ACS), coronary syndromes, myocardial infarction (MI), and heart failure. Some of the cardiac biomarkers include creatine kinase (CK) MB, troponins (cTnI and cTnT), BNP, NT-proBNP, GFAP, H-FABP, LDH isoenzymes, D-dimer, IMA, ...  |  read more...
USD 3,000
Trinity College Dublin - Product Pipeline Analysis, 2014 Update
10/17/2014 | published by: GlobalData
... and short courses in music, drama, history, English, languages, classics, philosophy and psychology. Trinity’s departments comprise faculty of engineering, mathematics and science and faculty of health sciences. The college offers accommodation and catering services, careers ...  |  read more...
USD 750
Human Microbiome Market by Disease (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder), Application (Therapeutic, Diagnostic) & by Product (Probiotic, Prebiotic, Food, Medical Food, Supplement, Device, Drug) – Global Forecast to 2023
9/10/2014 | published by: MarketsandMarkets
... diagnosis and efficient treatment with microbiome therapy for maintaining healthy lifestyle will boost the human microbiome market The product segment is expected to account for the largest share of the human microbiome market in the ...  |  read more...
USD 4,650
POCT Market in China : 2014-2018
9/10/2014 | published by: TechNavio - Infiniti Research Ltd.
... is gaining popularity due to the increasing incidence and prevalence of lifestyle diseases such as diabetes, heart disease, and obesity. It is generally cost-effective and user-friendly. POCT devices are standardized to minimize errors during the ...  |  read more...
USD 2,500
MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets
9/1/2014 | published by: BCC Research
... $572 million in 2014 and $1 billion in 2019, at a compound annual growth rate (CAGR) of 12.6% for the period of 2014 to 2019. This report provides: An overview of the global market for ...  |  read more...
USD 6,650
Autoimmune Disease Diagnostics: Global Markets
9/1/2014 | published by: BCC Research
... 2019, with a compound annual growth rate (CAGR) of 1.6% for the five-year period, 2014 to 2019. This report provides: An overview of the global market for autoimmune disease diagnostics. Analyses of global market trends, ...  |  read more...
USD 6,650
Companion Diagnostics Markets (Cancer, Cardiovascular and Blood, Metabolic, Infection, Neurological, Others)
8/8/2014 | published by: Kalorama Information
... with several of them part of a routine diagnostic and treatment plan. This report tracks these developments and provides detailed examples of drug-test pairs.  It also provides market estimation and forecast models for business planning. ...  |  read more...
USD 3,995
Mass Spectrometry in Clinical Applications (MALDI-TOF, Triple Quad, QTRAP, Ion Trap, GCMS, Orbitrap & Ion-Orbitrap, QTOF, Other Mass Spec)
4/29/2014 | published by: Kalorama Information
... and End User Survey , looks at the growth of Mass Spec systems being used in diagnostics and other clinical applications this year.  A Detailed Examination of the Market Opportunity for MS in Clinical Applications ...  |  read more...
USD 4,400
USD 19,700
USD 6,100
USD 6,100
USD 6,100
USD 3,850
USD 3,850
USD 4,850
USD 3,850
USD 3,850
Biomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders
7/1/2014 | published by: CHI Insight Pharma Reports
... development. Biomarkers have been a heavily studied topic of interest, and recently on the rise is the interest in neurodegenerative disorders. Although there are many techniques used to track neurodegenerative disease progression, this report will ...  |  read more...
USD 2,495
Biomarkers in Alzheimer's Disease
8/1/2014 | published by: CHI Insight Pharma Reports
... Disorders, this report focuses on the Alzheimer’s Disease space featured in the parent report, highlighting several biomarker targets under investigation and the progress that has been made in the industry. With regards to employing the ...  |  read more...
USD 699
< prev 1    3  4  5  6